mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]

Retatrutide is an investigational first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist

As far as diabetes sub classification terminology is concerned, from a purely theoretical and abstract perspective, it is academically acknowledged that the sub classifications of diabetes is theoretically, numerically, and mathematically incoherent

But the mechanistic rationale is sound, since the NF-kB and cytokine pathways that GLP-1 modulates are directly involved in Hashimoto pathogenesis

This body of data suggests that there may be synergistic activity between GLP1 agonist and other metabolic pathway therapies

Methods A MEDLINE search, limited to human clinical trials and using the search criteria GLP-1RA or DPP-4 inhibitor, identified seven head-to-head studies and one relevant post hoc analysis (all a GLP-1RA vs